Dr. Vince Clinical Research is a full-service CRO built specifically for early phase drug development
We specialize in Phase I-III clinical trials across a wide range of study designs, therapeutic areas and drug classes, conducted at our physician-led research facility and through our network of strategic site partners. Our approach emphasizes proactive planning and operational execution to reduce risk throughout the study lifecycle.
How we are built differently
Our approach reflects how we operate day to day, guided by four pillars that shape every study we conduct.
Flexible partner
Our unit is physician-led, and decisions are made by the experienced leaders closest to the study. This lets us adapt to evolving study needs and keep timelines on track without slowing execution.
Team continuity
The same experienced team supports your study from start-up through closeout. Consistent leadership preserves institutional knowledge and accountability and helps sponsors avoid staffing changes that can interrupt momentum in early development.
Smarter Faster Data®
Our fully integrated technology platform, including eSource, EDC and CTMS, along with AI-driven tools, help streamline data collection throughout the study. These secure, cloud-based systems provide real-time data visibility, validated audit trails, data integration and access to reliable, high-quality data across the entire study lifecycle.
Speed & quality
Sponsors have direct access to the clinical and operational leads responsible for their study, enabling rapid communication throughout execution and the delivery of submission-ready data faster than industry standards.
Your Full-Service CRO™
We provide full-service support across the early phase lifecycle, from first-in-human through Phase I-III multicenter patient trials. Our study types include:
Studies are run at our 80,000 square-foot research campus, which houses a 100-bed Phase I clinical pharmacology unit, an in-house clinical laboratory for on-site safety testing and a cGMP-compliant pharmacy licensed for controlled substances. Bringing these capabilities under one roof supports faster start-up and consistent execution from screening through database lock.
Our leadership
Our work is guided by an experienced leadership team, hand-selected across clinical, operational, scientific and regulatory disciplines and supported by over 300 employees globally. The company was founded by Bradley D. Vince, DO, our CEO and Chief Medical Officer. Dr. Vince has more than 25 years of experience in the clinical research industry and has served as an investigator in over 750 clinical trials.
Careers
We empower our people to deliver customer excellence for our sponsors, fostering an environment where employees feel inspired, confident, and fulfilled through comprehensive benefits and a collaborative culture.
Looking to do meaningful early phase work alongside an experienced team?
Considering DVCR for your early phase program?
Talk to a team built specifically for early phase execution.
Explore how our experts can help advance your clinical program. Our team works with you to identify potential challenges early and establish a clear execution plan.
